ALTAMURA, CLAUDIA
 Distribuzione geografica
Continente #
AS - Asia 6.965
NA - Nord America 1.931
EU - Europa 1.029
SA - Sud America 530
AF - Africa 49
OC - Oceania 13
AN - Antartide 1
Totale 10.518
Nazione #
SG - Singapore 5.326
US - Stati Uniti d'America 1.856
CN - Cina 689
IT - Italia 489
HK - Hong Kong 459
BR - Brasile 407
VN - Vietnam 216
GB - Regno Unito 136
FR - Francia 118
DE - Germania 88
BD - Bangladesh 66
IN - India 56
AR - Argentina 52
CA - Canada 38
ID - Indonesia 33
NL - Olanda 30
EC - Ecuador 26
EE - Estonia 22
FI - Finlandia 21
MX - Messico 19
RU - Federazione Russa 19
TR - Turchia 17
AT - Austria 15
UA - Ucraina 15
ZA - Sudafrica 15
IQ - Iraq 13
JP - Giappone 13
AU - Australia 12
CO - Colombia 11
PH - Filippine 11
ES - Italia 10
SA - Arabia Saudita 10
SE - Svezia 10
MD - Moldavia 9
PK - Pakistan 9
CZ - Repubblica Ceca 8
MA - Marocco 8
MY - Malesia 8
PL - Polonia 8
CL - Cile 7
PE - Perù 7
PY - Paraguay 7
VE - Venezuela 7
DZ - Algeria 5
HR - Croazia 5
KZ - Kazakistan 5
TN - Tunisia 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
JM - Giamaica 4
LT - Lituania 4
NP - Nepal 4
AL - Albania 3
BE - Belgio 3
BO - Bolivia 3
EG - Egitto 3
GE - Georgia 3
GR - Grecia 3
KR - Corea 3
PT - Portogallo 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
MT - Malta 2
OM - Oman 2
PS - Palestinian Territory 2
RO - Romania 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GY - Guiana 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MS - Montserrat 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SO - Somalia 1
YT - Mayotte 1
Totale 10.518
Città #
San Jose 724
Hong Kong 453
Singapore 433
Ashburn 390
Rome 291
Hefei 237
Beijing 172
Dallas 124
Boardman 113
London 109
Lauterbourg 102
Shanghai 80
Ho Chi Minh City 76
Hanoi 53
New York 48
São Paulo 43
Santa Clara 30
Los Angeles 29
Munich 29
Council Bluffs 28
San Francisco 27
Sona 22
Milan 19
Pune 18
Amsterdam 14
Seattle 14
Nuremberg 13
Toronto 13
Florence 11
Frankfurt am Main 11
Washington 11
Helsinki 10
Montreal 10
Quito 10
Rio de Janeiro 10
Tokyo 10
West Jordan 10
Chennai 9
Guayaquil 9
Redmond 9
Turku 9
Brasília 8
Stockholm 8
Warsaw 8
Baghdad 7
Joinville 7
Mexico City 7
Porto Alegre 7
Bologna 6
Brno 6
Haiphong 6
Boston 5
Brooklyn 5
Buffalo 5
Can Tho 5
Dhaka 5
Edinburgh 5
Genoa 5
Istrana 5
Johannesburg 5
Lima 5
Manaus 5
Manchester 5
Melbourne 5
Miami 5
Phoenix 5
Quảng Ngãi 5
Santa Fe 5
Tashkent 5
Turin 5
Vienna 5
Buenos Aires 4
Caxias do Sul 4
Charlotte 4
Chicago 4
Da Nang 4
Delhi 4
Feira de Santana 4
Ha Long 4
Hortolândia 4
Jeddah 4
Kathmandu 4
Ninh Bình 4
Niterói 4
Osasco 4
Paris 4
Riyadh 4
Salvador 4
Sydney 4
Tunis 4
Vũng Tàu 4
Asunción 3
Athens 3
Bắc Giang 3
Caivano 3
Central 3
Centro 3
Cuenca 3
Curitiba 3
Dakar 3
Totale 4.110
Nome #
1-Hz repetitive transcranial magnetic stimulation increases cerebral vasomotor reactivity: a possible autonomic nervous system modulation 390
Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: A correlation study in patients with cognitive impairment 249
Stroke territory and atherosclerosis in ischemic stroke patients with a history of migraine with aura 247
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 247
Psychopathological variables in chronic migraine patients with different therapeutic approach: psychological profile differences and impact on therapeutic efficacy in real life 230
Task-switching abilities in episodic and chronic migraine 227
Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment 226
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 224
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study 220
Acute Carotid Dissection in an Adult Caused by Pertussis 220
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project 214
Correction to: Task-switching abilities in episodic and chronic migraine (Neurological Sciences, (2022), 10.1007/s10072-021-05837-4) 213
Eptinezumab for the Prevention of Migraine: Clinical Utility, Patient Preferences and Selection - A Narrative Review 202
Cerebral Hemodynamics, Right-to-Left Shunt and White Matter Hyperintensities in Patients with Migraine with Aura, Young Stroke Patients and Controls 200
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 199
Cerebral distribution of white matter lesions in migraine with aura patients 198
CAROTID WALL THICKNESS AND STROKE RISK IN PATIENTS WITH ASYMPTOMATIC INTERNAL CAROTID STENOSIS 194
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment 193
Cerebral vasomotor reactivity in the acute phase and after 6 months in non-disabling stroke/TIA: A prospective cohort study 187
Right-to-Left Shunt and the Clinical Features of Migraine with Aura: Earlier but Not More 181
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 148
Frequency and clinical implications of hypercoagulability states in a cohort of patients with migraine with aura 143
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study 140
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study 135
Gepants - a long way to cure: a narrative review 120
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study 119
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 118
Carotid Artery Plaque Progression: Proposal of a New Predictive Score and Role of Carotid Intima-Media Thickness 117
Acute medications' intake for migraine: a one-year report in patients undergoing first evaluation at a third level Italian headache center 116
Relationship among diffusion tensor imaging, EEG activity, and cognitive status in mild cognitive impairment and Alzheimer's disease patients 114
Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia 113
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 112
Embodying an artificial hand increases blood flow to the investigated limb [version 3; peer review: 2 approved] 111
Bilateral MCP Infarct Due to Vertebral Giant Cell Arteritis 109
Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study 107
Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease 104
Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease 103
Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia 103
Cerebrovascular assessment for the risk prediction of Alzheimer's disease 101
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study 101
Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study 100
Ceruloplasmin/Transferrin system is related to clinical status in acute stroke 99
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairment 99
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 94
Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles-A Narrative Review 93
Patients with migraine with aura have increased flow mediated dilation 87
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 81
The role of endothelial dysfunction in the pathophysiology and cerebrovascular effects of migraine: A narrative review 77
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study) 67
Vascular predictors of cognitive decline in patients with mild cognitive impairment 60
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 58
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 57
Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study 57
fMRI-vs-MEG evaluation of post-stroke interhemispheric asymmetries in primary sensorimotor hand areas 57
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 57
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 56
Cognitive performance is related to ceruloplasmin/transferrin system in patients with chronic hepatitis 56
Erenumab does not alter cerebral hemodynamics and endothelial function in migraine without aura 55
Cortical neuromodulation modifies cerebral vasomotor reactivity 55
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 55
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study 54
Patent foramen ovale and migraine with aura in a retrospective analysis: age matters 53
Markers of lacunar stroke in patients with moderate internal carotid artery stenosis 53
Does cerebrovascular disease affect the coupling between neuronal activity and local haemodynamics? 53
Pathophysiological Bases of Comorbidity in Migraine 52
Cortical ischemic lesion burden measured by DIR is related to carotid artery disease severity 51
Serotonin depletion and barrel cortex development: impact of growth impairment vs. serotonin effects on thalamocortical endings 50
Markers for the risk of progression from mild cognitive impairment to Alzheimer's disease 50
Emerging Risk Factors for Dementia: The Role of Blood Pressure Variability 50
Shorter visual aura characterizes young and middle-aged stroke patients with migraine with aura 50
The evolving concept of multimorbidity and migraine 50
Gadolinium Enhancement in a Case of Uncomplicated Posterior Reversible Encephalopathy Syndrome 49
Thresholds of impaired cerebral hemodynamics that predict short-term cognitive decline in asymptomatic carotid stenosis 49
Internal jugular vein valve incompetence in transient global amnesia: more circumstantial evidence or the proof solving the mystery? 49
High frequency repetitive transcranial magnetic stimulation decreases cerebral vasomotor reactivity 46
Dorsolateral medullary ischemic infarction causing autonomic dysfunction and headache: a case report 45
The Healthy Eating Plate Advice for Migraine Prevention: An Interventional Study 45
Ruolo delle mappe ADC nella diagnosi differenziale tra demenza vascolare e demenza di Alzheimer 44
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men 44
When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway? 44
Ultrasonographic markers of vascular risk in patients with asymptomatic carotid stenosis 43
The Role of White Matter Damage in the Risk of Periprocedural Diffusion-Weighted Lesions after Carotid Artery Stenting. 42
Hypercapnia affects the functional coupling of resting state electroencephalographic rhythms and cerebral haemodynamics in healthy elderly subjects and in patients with amnestic mild cognitive impairment 42
Onabotulinumtoxin-A in Chronic Migraine: Should Timing and Definition of Non-Responder Status Be Revised? Suggestions From a Real-Life Italian Multicenter Experience 41
Neuroimaging experimental studies on brain plasticity in recovery from stroke 40
Cognitive deterioration in bilateral asymptomatic severe carotid stenosis 40
One-year progression of moderate asymptomatic carotid stenosis predicts the risk of vascular events 40
What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia? 40
Influence of chronotype on migraine characteristics 38
Neuronal functionality assessed by magnetoencephalography is related to oxidative stress system in acute ischemic stroke 38
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study) 38
Right-to-left shunts and hormonal therapy influence cerebral vasomotor reactivity in patients with migraine with aura 37
Hemoglobin oxygen saturation as a marker of cerebral hemodynamics in carotid artery occlusion : An integrated transcranial doppler and near-infrared spectroscopy study 37
Daith Piercing in a Case of Chronic Migraine: A Possible Vagal Modulation 37
Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome 37
Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration 37
Early activation of intracranial collateral vessels influences the outcome of spontaneous internal carotid artery dissection 37
Excessive daytime sleepiness is associated to the development of swallowing impairment in a cohort of early stage drug naïve Parkinson's disease patients 37
Transient global amnesia and jugular vein incompetence response 36
Lack of correlation between cerebral vasomotor reactivity and flow-mediated dilation in subjects without vascular disease 36
Totale 9.969
Categoria #
all - tutte 54.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.242


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022131 0 0 3 0 0 0 0 0 17 4 0 107
2022/202366 2 2 2 2 7 4 4 11 7 4 17 4
2023/2024348 17 40 12 31 36 144 5 27 6 10 9 11
2024/20255.796 43 44 123 11 14 68 106 62 322 411 2.235 2.357
2025/20264.228 371 258 339 588 177 218 1.084 235 345 319 254 40
Totale 10.569